<DOC>
	<DOCNO>NCT00367874</DOCNO>
	<brief_summary>Managed detoxification first necessary step prior treatment rehabilitation . Detoxification major obstacle patient , availability manage safe withdrawal prerequisite long-term treatment . In clinical practice felt need standardise safe detoxification treatment regimen opioid addict , dependence multiple drug common . Objectives 1 . To assess whether novel standardise treatment regimen - Buprenorphine ( BPN ) combine Valproate ( VPA ) - result few withdrawal symptom detoxification opiateâ€“polydrug user exist treatment regimen , i.e . Clonidine ( CLN ) combine Carbamazepine ( CBZ ) . 2 . To determine whether difference treatment retention BPN/VPA CLN/CBZ group . 3 . To assess difference clinical side-effects biochemical interaction two treatment regimen .</brief_summary>
	<brief_title>Treatment Polydrug-Using Opiate Dependents During Withdrawal</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Substance Withdrawal Syndrome</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Polydrug dependency ( least opiate benzodiazepine dependency ) No severe psychiatric illness No history epilepsy seizures No pregnancy breastfeed Fertile woman must use contraceptive</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>Opiate dependence</keyword>
	<keyword>Benzodiazepine dependence</keyword>
	<keyword>Polydrug Abuse</keyword>
	<keyword>Detoxification</keyword>
	<keyword>Withdrawal Treatment</keyword>
</DOC>